دورية أكاديمية
Conventional and microwave-assisted organic synthesis of novel antimycobacterial agents bearing furan and pyridine hybrids.
العنوان: | Conventional and microwave-assisted organic synthesis of novel antimycobacterial agents bearing furan and pyridine hybrids. |
---|---|
المؤلفون: | Desai NC; Division of Medicinal Chemistry, Department of Chemistry, Mahatma Gandhi Campus, Maharaja Krishnakumarsinhji Bhavnagar University, Bhavnagar, India., Bhatt K; Division of Medicinal Chemistry, Department of Chemistry, Mahatma Gandhi Campus, Maharaja Krishnakumarsinhji Bhavnagar University, Bhavnagar, India., Jadeja DJ; Division of Medicinal Chemistry, Department of Chemistry, Mahatma Gandhi Campus, Maharaja Krishnakumarsinhji Bhavnagar University, Bhavnagar, India., Mehta HK; Division of Medicinal Chemistry, Department of Chemistry, Mahatma Gandhi Campus, Maharaja Krishnakumarsinhji Bhavnagar University, Bhavnagar, India., Khedkar VM; School of Pharmacy, Vishwakarma University, Pune, India., Sarkar D; Combichem Bio-resource Centre, CSIR-National Chemical Laboratory, Pune, India. |
المصدر: | Drug development research [Drug Dev Res] 2022 Apr; Vol. 83 (2), pp. 416-431. Date of Electronic Publication: 2021 Aug 20. |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8204468 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-2299 (Electronic) Linking ISSN: 02724391 NLM ISO Abbreviation: Drug Dev Res Subsets: MEDLINE |
أسماء مطبوعة: | Publication: New York Ny : Wiley-Liss Original Publication: New York : Alan R. Liss, c1981- |
مواضيع طبية MeSH: | Mycobacterium tuberculosis* , Tuberculosis*/drug therapy, Antitubercular Agents/chemistry ; Chemistry Techniques, Synthetic ; Furans/pharmacology ; Furans/therapeutic use ; Humans ; Microbial Sensitivity Tests ; Microwaves ; Molecular Docking Simulation ; Pyridines/pharmacology ; Structure-Activity Relationship |
مستخلص: | Drug resistance in tuberculosis poses a serious threat to humanity because currently available antitubercular drugs are ineffective against Mycobacterium tuberculosis (M. tuberculosis). As a result, the approval of Bedaquiline and Delamanid for the treatment of drug-resistant tuberculosis was accelerated. Still, there is an urgent need to search for new antitubercular drugs with novel mechanisms of action (MoA). Due to this, we have designed a synthetic strategy by utilizing microwave-assisted organic synthesis. We have compared our method with the conventional procedure, and the data show that our procedure is more effective in the preparation of title compounds. A unique series of 1-(2-(furan-2-yl)-5-(pyridin-4-yl)-1,3,4-oxadiazol-3(2H)-yl)-3-(aryl)-prop-2-en-1-ones (5a-o) was synthesized utilizing conventional and microwave-assisted techniques. Synthetic compounds were investigated for antitubercular activity against Mycobacterium TB H (© 2021 Wiley Periodicals LLC.) |
References: | Ambhore, A. N., Kamble, S. S., Kadam, S. N., Kamble, R. D., Hebade, M. J., Hese, S. V., Gaikwad, M. V., Meshram, R. J., Gacche, R. N., & Dawane, B. S. (2019). Design, synthesis and in silico study of pyridine based 1, 3, 4-oxadiazole embedded hydrazinecarbothioamide derivatives as potent anti-tubercular agent. Computational Biology and Chemistry, 80, 54-65. Chiarelli, L. R., Mori, M., Beretta, G., Gelain, A., Pini, E., Sammartino, J. C., Stelitano, G., Barlocco, D., Costantino, L., Lapillo, M., & Poli, G. (2019). New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents. Journal of Enzyme Inhibition and Medicinal Chemistry, 34(1), 823-828. Desai, N. C., Jadeja, K. A., Jadeja, D. J., Khedkar, V. M., & Jha, P. C. (2020). Design, synthesis, antimicrobial evaluation, and molecular docking study of some 4-thiazolidinone derivatives containing pyridine and quinazoline moiety. Synthetic Communications, 51(6), 952-963. Desai, N. C., Mehta, H. K., & Harsora, J. P. (2021). 2-Pyridone quinoline hybrids as potent antibacterial and antifungal agents. Indian Journal of Chemistry-Section B (IJC-B), 60(2), 261-266. Desai, N. C., Trivedi, A., Somani, H., Jadeja, K. A., Vaja, D., Nawale, L., Khedkar, V. M., & Sarkar, D. (2018). Synthesis, biological evaluation, and molecular docking study of pyridine clubbed 1, 3, 4-oxadiazoles as potential antituberculars. Synthetic Communications, 48(5), 524-540. Desai, N. C., Vaghani, H. V., Jethawa, A. M., & Khedkar, V. M. (2021). In silico molecular docking studies of oxadiazole and pyrimidine bearing heterocyclic compounds as potential antimicrobial agents. Archiv der Pharmazie, e2100134. https://doi.org/10.1002/ardp.202100134. Dewangan, D., Pandey, A., Sivakumar, T., Rajavel, R., & Dubey, R. D. (2010). Synthesis of some novel 2, 5-disubstituted 1, 3, 4-oxadiazole and its analgesic, anti-inflammatory, anti-bacterial and anti-tubercular activity. International Journal of ChemTech Research, 2(3), 1397-1412. Dhumal, S. T., Deshmukh, A. R., Bhosle, M. R., Khedkar, V. M., Nawale, L. U., Sarkar, D., & Mane, R. A. (2016). Synthesis and antitubercular activity of new 1, 3, 4-oxadiazoles bearing pyridyl and thiazolyl scaffolds. Bioorganic & Medicinal Chemistry Letters, 26(15), 3646-3651. El-Etrawy, A. A. S., & Sherbiny, F. F. (2021). Design, synthesis, biological assessment and molecular docking studies of some new 2-Thioxo-2, 3-dihydropyrimidin-4 (1H)-ones as potential anticancer and antibacterial agents. Journal of Molecular Structure, 1225, 129014. Eryılmaz, S., Çelikoğlu, E. T., İdil, Ö., İnkaya, E., Kozak, Z., Mısır, E., & Gül, M. (2020). Derivatives of pyridine and thiazole hybrid: Synthesis, DFT, biological evaluation via antimicrobial and DNA cleavage activity. Bioorganic Chemistry, 95, 103476. Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A., Klicic, J. J., Mainz, D. T., Repasky, M. P., Knoll, E. H., Shelley, M., Perry, J. K., & Shaw, D. E. (2004). Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. Journal of Medicinal Chemistry, 47(7), 1739-1749. Gler, M. T., Skripconoka, V., Sanchez-Garavito, E., Xiao, H., Cabrera-Rivero, J. L., Vargas-Vasquez, D. E., Gao, M., Awad, M., Park, S. K., Shim, T. S., & Suh, G. Y. (2012). Delamanid for multidrug-resistant pulmonary tuberculosis. New England Journal of Medicine, 366(23), 2151-2160. Halgren, T. A., Murphy, R. B., Friesner, R. A., Beard, H. S., Frye, L. L., Pollard, W. T., & Banks, J. L. (2004). Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. Journal of Medicinal Chemistry, 47(7), 1750-1759. Henary, M., Kananda, C., Rotolo, L., Savino, B., Owens, E. A., & Cravotto, G. (2020). Benefits and applications of microwave-assisted synthesis of nitrogen containing heterocycles in medicinal chemistry. RSC Advances, 10(24), 14170-14197. Kakkar, A. K., & Dahiya, N. (2014). Bedaquiline for the treatment of resistant tuberculosis: Promises and pitfalls. Tuberculosis, 94(4), 357-362. Kantevari, S., Yempala, T., Surineni, G., Sridhar, B., Yogeeswari, P., & Sriram, D. (2011). Synthesis and antitubercular evaluation of novel dibenzo [b, d] furan and 9-methyl-9H-carbazole derived hexahydro-2H-pyrano [3, 2-c] quinolines via Povarov reaction. European Journal of Medicinal Chemistry, 46(10), 4827-4833. Kappe, C. O. (2008). Microwave dielectric heating in synthetic organic chemistry. Chemical Society Reviews, 37(6), 1127-1139. Kappe, C. O., & Dallinger, D. (2006). The impact of microwave synthesis on drug discovery. Nature Reviews Drug Discovery, 5(1), 51-63. Khan, A., & Sarkar, D. (2008). A simple whole cell based high throughput screening protocol using Mycobacterium bovis BCG for inhibitors against dormant and active tubercle bacilli. Journal of Microbiological Methods, 73(1), 62-68. Khan, A., Sarkar, S., & Sarkar, D. (2008). Bactericidal activity of 2-nitroimidazole against the active replicating stage of Mycobacterium bovis BCG and Mycobacterium tuberculosis with intracellular efficacy in THP-1 macrophages. International Journal of Antimicrobial Agents, 32(1), 40-45. Khan, S. A., Ahuja, P., & Husain, A. (2017). Oxidative cyclization of isoniazid with fluoroquinolones: Synthesis, antibacterial and antitubercular activity of new 2, 5-disubstituted-1, 3, 4-oxadiazoles. Journal of the Chinese Chemical Society, 64(8), 918-924. Kumar, A., Kuang, Y., Liang, Z., & Sun, X. (2020). Microwave chemistry, recent advancements and eco-friendly microwave-assisted synthesis of nanoarchitectures and their applications: A review. Materials Today Nano, 100076, 11,. Mejía-Gutiérrez, M., Olivero-Verbel, J., Quiroga, J., Romo, P., Castaño, S., & Fierro, L. (2020). Prediction of the potential biological activity of novel spiropyrazolo [3, 4-b] pyridines and spiropyrazolo [3, 4-b] pyridine-5, 5′-pyrimidines by a ligand-protein inverse-docking approach. Journal of Molecular Graphics and Modelling, 97, 107581. Ningegowda, R., Chandrashekharappa, S., Singh, V., Mohanlall, V., & Venugopala, K. N. (2020). Design, synthesis and characterization of novel 2-(2, 3-dichlorophenyl)-5-aryl-1, 3, 4-oxadiazole derivatives for their anti-tubercular activity against Mycobacterium tuberculosis. Chemical Data Collections, 28, 100431. Sarkar, S., & Sarkar, D. (2012). Potential use of nitrate reductase as a biomarker for the identification of active and dormant inhibitors of Mycobacterium tuberculosis in a THP1 infection model. Journal of Biomolecular Screening, 17(7), 966-973. Singh, R., Nawale, L. U., Arkile, M., Shedbalkar, U. U., Wadhwani, S. A., Sarkar, D., & Chopade, B. A. (2015). Chemical and biological metal nanoparticles as antimycobacterial agents: A comparative study. International Journal of Antimicrobial Agents, 46(2), 183-188. Singh, U., Akhtar, S., Mishra, A., & Sarkar, D. (2011). A novel screening method based on menadione mediated rapid reduction of tetrazolium salt for testing of anti-mycobacterial agents. Journal of Microbiological Methods, 84(2), 202-207. Takayama, K., Wang, C., & Besra, G. S. (2005). Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis. Clinical Microbiology Reviews, 18(1), 81-101. Tan, B., Zhang, X., Quan, X., Zheng, G., Li, X., Zhao, L., Li, W., & Li, B. (2020). Design, synthesis and biological activity evaluation of novel 4-(((1-cyclopropyl-3-(tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-yl) oxy) pyridine-2-yl) amino derivatives as potent transforming growth factor-β (TGF-β) type I receptor inhibitors. Bioorganic & Medicinal Chemistry Letters, 30(16), 127339. Thomas, A. B., Nanda, R. K., Kothapalli, L. P., & Hamane, S. C. (2016). Synthesis and biological evaluation of Schiff's bases and 2-azetidinones of isonocotinyl hydrazone as potential antidepressant and nootropic agents. Arabian Journal of Chemistry, 9, S79-S90. Unissa, A. N., Subbian, S., Hanna, L. E., & Selvakumar, N. (2016). Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis. Infection, Genetics and Evolution, 45, 474-492. Verma, R., Boshoff, H. I., Arora, K., Bairy, I., Tiwari, M., Varadaraj, B. G., & Shenoy, G. G. (2020). Synthesis, evaluation, molecular docking, and molecular dynamics studies of novel N-(4-[pyridin-2-yloxy] benzyl) arylamine derivatives as potential antitubercular agents. Drug Development Research, 81(3), 315-328. Yan, M., Xu, L., Wang, Y., Wan, J., Liu, T., Liu, W., Wan, Y., Zhang, B., Wang, R., & Li, Q. (2020). Opportunities and challenges of using five-membered ring compounds as promising antitubercular agents. Drug Development Research, 81(4), 402-418. Yempala, T., Sridevi, J. P., Yogeeswari, P., Sriram, D., & Kantevari, S. (2014). Rational design and synthesis of novel dibenzo [b, d] furan-1, 2, 3-triazole conjugates as potent inhibitors of Mycobacterium tuberculosis. European Journal of Medicinal Chemistry, 71, 160-167. |
فهرسة مساهمة: | Keywords: antitubercular activity; microwave-assisted organic synthesis; molecular docking |
المشرفين على المادة: | 0 (Antitubercular Agents) 0 (Furans) 0 (Pyridines) |
تواريخ الأحداث: | Date Created: 20210820 Date Completed: 20220502 Latest Revision: 20220524 |
رمز التحديث: | 20240628 |
DOI: | 10.1002/ddr.21872 |
PMID: | 34414591 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1098-2299 |
---|---|
DOI: | 10.1002/ddr.21872 |